一个生物灵感的聚合物膜封闭的胰岛素晶体实现了长期的,自我调节的药物释放,用于1型糖尿病治疗
Jianchang Xu1,2, Yang Zhang1,2, Sheng Zhao1,2
1State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
Nature nanotechnology
|February 26, 2025
概括
研究人员创造了一种新的自我调节的胰岛素输送系统. 这个系统模仿细胞核提供长期糖尿病治疗,释放胰岛素作为对葡萄糖和水平的反应.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 内分泌学 在内分泌学.
背景情况:
- 核外调节了核与细胞质之间的运输.
- 目前的糖尿病疗法需要经常注射胰岛素.
- 开发自我调节的药物输送系统对于改善患者的治疗结果至关重要.
研究的目的:
- 开发一种新的聚合物纳米膜系统,用于持续和自我调节的胰岛素输送.
- 创建一个模仿细胞核调节功能的系统.
- 为了实现葡萄糖和β-基酸触发的胰岛素释放,以改善糖尿病管理.
主要方法:
- 在胰岛素晶体上的纳米多孔聚合物纳米膜的现场合成.
- 将对葡萄糖和β-酸敏感的微域集成到纳米膜中.
- 在1型糖尿病小鼠和小猪体内测试以评估血糖控制和胰岛素释放.
主要成果:
- 纳米膜系统展示了持续的,可调节的,零顺序的胰岛素释放动力学.
- 集成的微域使双触发胰岛素释放在高葡萄糖和β-基酸盐水平的反应.
- 持续的正常血糖在小鼠中持续超过1个月,在小猪中持续3周.
结论:
- 开发的模仿细胞核的系统为长效,自我调节的胰岛素治疗提供了一个有希望的平台.
- 这种配方为控制药物释放应用提供了广泛的方法.
- 该系统在1型糖尿病的临床前模型中有效管理高血糖和血症.
相关概念视频
Insulin: Biosynthesis, Chemistry, and Preparation
338
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
338
Insulin Formulations: Types and Delivery
160
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
160
Glucagon-like Receptor Agonists
291
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
291
Insulin Secretory Vesicles
4.8K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.8K
Insulin: Dosing Regimen and Adverse Effects
137
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
137
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.0K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.0K


